BRLVX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BRLVX Analyst Rating

Moderate Buy

86 Buy

16 Hold

0 Sell

Based on the consensus analyst ratings on 102 stocks held in BRLVX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BRLVX Analyst Price Target

Average Price Target

$25.68

Based on 102 Wall Street analysts offering 12 month price targets to American Beacon Bridgeway Large Cap Value Fd Inst Cl holdings in the last 3 months. The average price target is $25.68 with a high forecast of $30.75 and a low forecast of $21.37. The average price target represents a 12.17% change from the last price of $22.89.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"$20","31":"$31","22.75":"$22.8","25.5":"$25.5","28.25":"$28.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30.746,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.675,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$25.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.367,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$21.37</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,22.75,25.5,28.25,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.34,23.909692307692307,24.479384615384614,25.049076923076925,25.61876923076923,26.18846153846154,26.758153846153846,27.327846153846153,27.89753846153846,28.467230769230767,29.036923076923074,29.606615384615385,30.17630769230769,{"y":30.746,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.34,23.519615384615385,23.69923076923077,23.878846153846155,24.05846153846154,24.238076923076925,24.417692307692306,24.59730769230769,24.776923076923076,24.95653846153846,25.136153846153846,25.31576923076923,25.495384615384616,{"y":25.675,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.34,23.18823076923077,23.036461538461538,22.88469230769231,22.732923076923075,22.581153846153846,22.429384615384617,22.277615384615384,22.125846153846155,21.974076923076925,21.822307692307692,21.670538461538463,21.51876923076923,{"y":21.367,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":25.17,"date":1717372800000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.95,"date":1719792000000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.03,"date":1722470400000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.5,"date":1725321600000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.11,"date":1727740800000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.09,"date":1730419200000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.82,"date":1733097600000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.81,"date":1735776000000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.98,"date":1738540800000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.6,"date":1740960000000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.01,"date":1743465600000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.4,"date":1746057600000,"info":"<div>Price: <b>$22<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.34,"date":1748822400000,"info":"<div>Price: <b>$23<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$30.75

Average Price Target$25.68

Lowest Price Target$21.37

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

BRLVX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

JAZZ

Jazz Pharmaceuticals

―

13 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DLB

Dolby Laboratories

―

4 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

REGN

Regeneron Pharmaceuticals

―

17 Buy

5 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRM

Salesforce.com

―

34 Buy

10 Hold

3 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BLDR

Builders Firstsource

―

11 Buy

4 Hold

0 Sell

Moderate Buy

―

BRLVX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

EBAY

Ebay Inc

―

10 Buy

15 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SWKS

Skyworks Solutions

―

1 Buy

13 Hold

4 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RTX

Rtx Corporation

―

12 Buy

5 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MKL

Markel Corporation

―

1 Buy

2 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CBOE

Cboe Global Markets

―

2 Buy

8 Hold

2 Sell

Hold

―

BRLVX Mutual Fund FAQ

What is BRLVX’s average 12-month price target, according to analysts?

Based on analyst ratings, American Beacon Bridgeway Large Cap Value Fd Inst Cl’s 12-month average price target is 25.68.

What is BRLVX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for BRLVX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BRLVX a Buy, Sell or Hold?

American Beacon Bridgeway Large Cap Value Fd Inst Cl has a consensus rating of Moderate Buy which is based on 86 buy ratings, 16 hold ratings and 0 sell ratings.

What is American Beacon Bridgeway Large Cap Value Fd Inst Cl’s price target?

The average price target for American Beacon Bridgeway Large Cap Value Fd Inst Cl is 25.68. This is based on 102 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.75 ,the lowest forecast is $21.37. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about American Beacon Bridgeway Large Cap Value Fd Inst Cl?

American Beacon Bridgeway Large Cap Value Fd Inst Cl’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 102 Wall Streets Analysts.

How can I buy shares of BRLVX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing